Why is $DNTH moving today? · SEC 8-K archive

$DNTH SEC Filing Alert & Real-Time AI Stock Impact Analysis

T0 SEO archive for $DNTH: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).

← All archive signals

FAQ: $DNTH filing catalyst

Why did $DNTH trigger an AI stock catalyst alert?

$DNTH triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: -1.0/10). Headline: Dianthus Therapeutics Reports Q3 Net Loss Widened to $46.6M ($0.81/Share). Key points: - Q3 net loss increased to $46.6 million or $0.81 per basic/diluted share, compared to $36.8 million ($0.97/share) in Q3 2025. - Operating expenses increased primarily due to advancing clinical pipelines including Phase 3 EMERGE trial. - Total assets reported at $1.28 billion with ongoing pipeline progress across neuromuscular indications.

How did $DNTH stock react after the SEC filing?

After the SEC 8-K for $DNTH, observed market reaction: T0 price $85.81. Past moves do not guarantee future results.

Where can I get real-time $DNTH SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $DNTH via Telegram and the VIP Web Terminal from €10/month.

$DNTH

$DNTH – Dianthus Therapeutics Reports Q3 Net Loss Widened to $46.6M ($0.81/Share)

Dianthus Therapeutics, Inc. /DE/

2026-11-04 00:00:00 UTC · SEC 8-K · All $DNTH

Unlocked archive · Analyzed in <2s at T0

Neutral AI Sentiment (-1.0 / 10)

Q3 net loss increased to $46.6 million or $0.81 per basic/diluted share, compared to $36.8 million ($0.97/share) in Q3 2025.
Operating expenses increased primarily due to advancing clinical pipelines including Phase 3 EMERGE trial.
Total assets reported at $1.28 billion with ongoing pipeline progress across neuromuscular indications.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →